Theratechnologies (NASDAQ:THTX) Posts Earnings Results

Theratechnologies (NASDAQ:THTX) issued its quarterly earnings results on Wednesday. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.04, Yahoo Finance reports. The company had revenue of $22.02 million during the quarter. During the same period in the prior year, the business posted ($0.40) EPS. Theratechnologies updated its FY 2024 guidance to EPS.

Theratechnologies Stock Down 3.3 %

THTX stock opened at $1.45 on Friday. Theratechnologies has a 52 week low of $0.88 and a 52 week high of $3.60. The business has a 50-day simple moving average of $1.30 and a 200 day simple moving average of $1.47.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.